JFGIW
IMVT icon

Johnson Financial Group Inc (Wisconsin)’s Immunovant IMVT Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89K Hold
75
– – ﹤0.01% 741
2026
Q1 		$1.86K Hold
75
– – ﹤0.01% 798
2025
Q4 		$1.91K Hold
75
– – ﹤0.01% 824
2025
Q3 		$1.21K Buy
+75
New +$1.21K ﹤0.01% 995

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Johnson Financial Group Inc (Wisconsin)'s IMVT Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its Immunovant (IMVT) position steady in Q2 2026 at 75 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #741.

Johnson Financial Group Inc (Wisconsin) first reported a position in IMVT in Q3 2025 and has held it in 4 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 75 shares of Immunovant worth $2.89K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #741 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Immunovant in Q3 2025 and has held it in 4 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.